Hostname: page-component-848d4c4894-wzw2p Total loading time: 0 Render date: 2024-06-09T08:58:23.222Z Has data issue: false hasContentIssue false
  • English
  • Français

Transcatheter utilisation of lifetech multifunction™ occluder device for closure of perimembranous and muscular ventricular septal defects: first use in North America

Part of: Interventional Cardiology Echocardiography Ventricular Septal Defect (VSD) Atrioventricular Septal Defect (AVSD)

Published online by Cambridge University Press:  26 March 2021

Kurt R. Bjorkman ,
Osamah Aldoss ,
Jennifer R. Maldonado Open the ORCID record for Jennifer R. Maldonado [Opens in a new window]  and
Daniel McLennan Open the ORCID record for Daniel McLennan [Opens in a new window]
Kurt R. Bjorkman
Affiliation:
Department of Pediatrics, Division of Pediatric Cardiology, University of Iowa Stead Family Children’s Hospital, Iowa City, IA, USA
Osamah Aldoss
Affiliation:
Department of Pediatrics, Division of Pediatric Cardiology, University of Iowa Stead Family Children’s Hospital, Iowa City, IA, USA
Jennifer R. Maldonado
Affiliation:
Department of Pediatrics, Division of Pediatric Cardiology, University of Iowa Stead Family Children’s Hospital, Iowa City, IA, USA
Daniel McLennan*
Affiliation:
Department of Pediatrics, Division of Pediatric Cardiology, University of Iowa Stead Family Children’s Hospital, Iowa City, IA, USA
*
Author for correspondence: D. McLennan, BMedSci, MBBS, FRACP, Department of Pediatrics, Division of Pediatric Cardiology, University of Iowa Stead Family Children’s Hospital, 200 Hawkins Drive – BT1010, Iowa City, IA52242, USA. Tel: +422 5099. E-mail: mclennan.daniel@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Transcatheter closure of ventricular septal defects is considered first-line therapy when anatomically appropriate but is often challenged by proximity to the conduction system in perimembranous defects, or irregular defect shape, especially residual defects that may remain post-operatively. Advancements in device design, however, have allowed for significant improvements in deployment techniques and overall safety. Here we describe the first use of the Lifetech Konar-multifunction™ occluder device in North America, and our specific use of this device to close complex post-operative muscular and a perimembranous-ventricular septal defects in the same patient.

Keywords

Heart defectscongenitalcardiac catheter
Type
Brief Report
Information
Cardiology in the Young , Volume 31 , Issue 9 , September 2021 , pp. 1525 - 1527
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Warnes, CA, Williams, RG, Bashore, TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52: e143–e263.CrossRefGoogle Scholar
Baumgartner, H, Taylor, J. The 2010 version of the ESC guidelines for the management of grown-up adult congenital heart disease are discussed by guidelines task force chairman H. Baumgartner. Eur Heart J 2010; 31: 2825–2826.Google Scholar
Tanidir, IC, Baspinar, O, Saygi, M, Kervancioglu, M, Guzeltas, A, Odemis, E. Use of LifetechTM Konar-MF, a device for both perimembranous and muscular ventricular septal defects: A multicentre study. Int J Cardiol 2020; 310: 43–50.CrossRefGoogle Scholar
Schubert, S, Kelm, M, Koneti, NR, Berger, F. First European experience of percutaneous closure of ventricular septal defects using a new CE-marked VSD occlude. EuroIntervention 2019; 15: e242–e243. doi: 10.4244/EIJ-D-18-00867 CrossRefGoogle Scholar
Haddad, RN, Daou, LS, Saliba, ZS. Percutaneous closure of restrictive-type perimembranous ventricular septal defect using the new KONAR multifunctional occluder: Midterm outcomes of the first middle-eastern experience. Catheter Cardiovasc Interv 2019. doi: 10.1002/ccd.28678 Google ScholarPubMed
Egorova, AD, Ewert, P, Hadamitzky, M, Eicken, A. Successful percutaneous occlusion of a large left circumflex coronary artery fistula draining into the coronary sinus using a ventricular septal defect occluder: a case report. Eur Heart J Case Rep 2020. https://academic.oup.com/ehjcr/article-abstract/doi/10.1093/ehjcr/ytaa029/5743152.CrossRefGoogle ScholarPubMed